ENTA
Price
$11.31
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
41 days until earnings call
LGVN
Price
$1.94
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
Ad is loading...

ENTA vs LGVN

Header iconENTA vs LGVN Comparison
Open Charts ENTA vs LGVNBanner chart's image
Enanta Pharmaceuticals
Price$11.31
Change-$0.00 (-0.00%)
Volume$110.8K
CapitalizationN/A
Longeveron
Price$1.94
Change-$0.00 (-0.00%)
Volume$591.55K
CapitalizationN/A
View a ticker or compare two or three
ENTA vs LGVN Comparison Chart
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ENTA vs. LGVN commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a StrongBuy and LGVN is a Hold.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (ENTA: $11.30 vs. LGVN: $1.95)
Brand notoriety: ENTA and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 60% vs. LGVN: 102%
Market capitalization -- ENTA: $212.95M vs. LGVN: $27.86M
ENTA [@Biotechnology] is valued at $212.95M. LGVN’s [@Biotechnology] market capitalization is $27.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ENTA and LGVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 4 TA indicator(s) are bullish while LGVN’s TA Score has 6 bullish TA indicator(s).

  • ENTA’s TA Score: 4 bullish, 4 bearish.
  • LGVN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than ENTA.

Price Growth

ENTA (@Biotechnology) experienced а -2.16% price change this week, while LGVN (@Biotechnology) price change was +7.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ENTA is expected to report earnings on Feb 05, 2025.

LGVN is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($213M) has a higher market cap than LGVN($27.9M). ENTA YTD gains are higher at: 20.085 vs. LGVN (-85.662). LGVN has higher annual earnings (EBITDA): -17.24M vs. ENTA (-104.08M). ENTA has more cash in the bank: 230M vs. LGVN (12.4M). LGVN has less debt than ENTA: LGVN (1.75M) vs ENTA (50.6M). ENTA has higher revenues than LGVN: ENTA (72M) vs LGVN (1.23M).
ENTALGVNENTA / LGVN
Capitalization213M27.9M763%
EBITDA-104.08M-17.24M604%
Gain YTD20.085-85.662-23%
P/E RatioN/AN/A-
Revenue72M1.23M5,858%
Total Cash230M12.4M1,855%
Total Debt50.6M1.75M2,895%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTALGVN
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ETNB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+2.36%
ETNB - ENTA
45%
Loosely correlated
+1.54%
INZY - ENTA
44%
Loosely correlated
+1.16%
ARWR - ENTA
42%
Loosely correlated
+4.99%
KROS - ENTA
41%
Loosely correlated
+1.20%
VIR - ENTA
40%
Loosely correlated
+1.05%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with SRPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
+8.94%
SRPT - LGVN
34%
Loosely correlated
-0.11%
ENTA - LGVN
34%
Loosely correlated
+2.36%
FATE - LGVN
33%
Loosely correlated
-1.29%
AXON - LGVN
30%
Poorly correlated
+0.69%
QURE - LGVN
30%
Poorly correlated
-0.18%
More